Global Bioequivalence Studies Market Size, Share, and COVID-19 Impact Analysis, By Molecule Type (Small Molecule and Large Molecule), By Dosage Form (Solid Oral Dosage, Parenteral Formulations, Topical Products, and Others), By Therapeutic Area (Oncology, Neurology, Metabolic Disorders, Hematology, Immunology, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 - 2032.

Industry: Healthcare
RELEASE DATE Jun 2023
REPORT ID SI2253
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Molecule Type
      2. Market Attractiveness Analysis By Dosage Form
      3. Market Attractiveness Analysis By Therapeutic Area
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rapid growth in the production and consumption of generic products
    3. Restraints
      1. High initial investment
    4. Opportunities
      1. Increased investment in R&D activities by manufacturers
  6. Global Bioequivalence Studies Market Analysis and Projection, By Molecule Type
    1. Segment Overview
    2. Small Molecule
    3. Large Molecule
  7. Global Bioequivalence Studies Market Analysis and Projection, By Dosage Form
    1. Segment Overview
    2. Solid Oral Dosage
    3. Parenteral Formulations
    4. Topical Products
    5. Others
  8. Global Bioequivalence Studies Market Analysis and Projection, By Therapeutic Area
    1. Segment Overview
    2. Oncology
    3. Neurology
    4. Metabolic Disorders
    5. Hematology
    6. Immunology
    7. Others
  9. Global Bioequivalence Studies Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Bioequivalence Studies Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Bioequivalence Studies Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. PRORELIX SERVICES LLP
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   ICON plc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  LABCORP DRUG DEVELOPMENT 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Veeda Clinical Research 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   CLINIEXPERTS 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  IQVIA
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Charles River Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8.  KYMOS Group 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Notrox Research
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  NorthEast BioAnalytical Laboratories LLC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Malvern Panalytical Ltd 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.  Synova Health
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Bioequivalence Studies Market, By Molecule Type, 2022-203(USD Million)
  2. Global Small Molecule, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  3. Global Large Molecule, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  4. Global Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  5. Global Solid Oral Dosage, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  6. Global Parenteral Formulations, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  7. Global Topical Products, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  8. Global Others, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  9. Global Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  10. Global Oncology, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  11. Global Neurology, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  12. Global Metabolic Disorders, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  13. Global Hematology, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  14. Global Immunology, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  15. Global Others, Bioequivalence Studies Market, By Region, 2022-2032(USD Million)
  16. North America Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  17. North America Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  18. North America Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  19. U.S.  Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  20. U.S.  Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  21. U.S.  Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  22. Canada Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  23. Canada Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  24. Canada Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  25. Mexico Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  26. Mexico Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  27. Mexico Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  28. Europe Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  29. Europe Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  30. Europe Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  31. Germany Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  32. Germany Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  33. Germany Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  34. France Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  35. France Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  36. France Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  37. U.K.  Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  38. U.K.  Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  39. U.K.  Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  40. Italy Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  41. Italy Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  42. Italy Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  43. Spain Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  44. Spain Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  45. Spain Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  46. Asia Pacific Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  47. Asia Pacific Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  48. Asia Pacific Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  49. Japan Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  50. Japan Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  51. Japan Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  52. China Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  53. China Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  54. China Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  55. India Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  56. India Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  57. India Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  58. South America Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  59. South America Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  60. South America Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  61. Brazil Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  62. Brazil Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  63. Brazil Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  64. The Middle East and Africa Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD   Million)
  65. The Middle East and Africa Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD   Million)
  66. The Middle East and Africa Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)
  67. UAE Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  68. UAE Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  69. UAE Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million) 
  70. South Africa Bioequivalence Studies Market, By Molecule Type, 2022-2032(USD Million)
  71. South Africa Bioequivalence Studies Market, By Dosage Form, 2022-2032(USD Million)
  72. South Africa Bioequivalence Studies Market, By Therapeutic Area, 2022-2032(USD Million)

List of Figures 

  1. Global Bioequivalence Studies Market Segmentation
  2. Bioequivalence Studies Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Bioequivalence Studies Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Bioequivalence Studies Market
  20. Bioequivalence Studies Market Segmentation, By Molecule Type
  21. Bioequivalence Studies Market For Small Molecule, By Region, 2022-2032 ($ Million)
  22.  Bioequivalence Studies Market For Large Molecule, By Region, 2022-2032 ($ Million)
  23.  Bioequivalence Studies Market Segmentation, By Dosage Form
  24.  Bioequivalence Studies Market For Solid Oral Dosage, By Region, 2022-2032 ($ Million)
  25.  Bioequivalence Studies Market For Parenteral Formulations, By Region, 2022-2032 ($ Million)
  26. Bioequivalence Studies Market For Topical Products, By Region, 2022-2032 ($ Million)
  27. Bioequivalence Studies Market For Others, By Region, 2022-2032 ($ Million)
  28. Bioequivalence Studies Market Segmentation, By Therapeutic Area
  29. Bioequivalence Studies Market For Oncology, By Region, 2022-2032 ($ Million)
  30. Bioequivalence Studies Market For Neurology, By Region, 2022-2032 ($ Million)
  31. Bioequivalence Studies Market For Metabolic Disorders, By Region, 2022-2032 ($ Million)
  32. Bioequivalence Studies Market For Hematology, By Region, 2022-2032 ($ Million)
  33. Bioequivalence Studies Market For Immunology, By Region, 2022-2032 ($ Million)
  34. Bioequivalence Studies Market For Others, By Region, 2022-2032 ($ Million)
  35. PRORELIX SERVICES LLP: Net Sales, 2022-2032 ($ Million)
  36. PRORELIX SERVICES LLP: Revenue Share, By Segment, 2022 (%)
  37. PRORELIX SERVICES LLP: Revenue Share, By Region, 2022 (%)
  38. ICON PLC: Net Sales, 2022-2032 ($ Million)
  39. ICON PLC: Revenue Share, By Segment, 2022 (%)
  40. ICON PLC: Revenue Share, By Region, 2022 (%)
  41. LABCORP DRUG DEVELOPMENT: Net Sales, 2022-2032 ($ Million)
  42. LABCORP DRUG DEVELOPMENT: Revenue Share, By Segment, 2022 (%)
  43. LABCORP DRUG DEVELOPMENT: Revenue Share, By Region, 2022 (%)
  44. Veeda Clinical Research: Net Sales, 2022-2032 ($ Million)
  45. Veeda Clinical Research: Revenue Share, By Segment, 2022 (%)
  46. Veeda Clinical Research: Revenue Share, By Region, 2022 (%)
  47. CLINIEXPERTS: Net Sales, 2022-2032 ($ Million)
  48. CLINIEXPERTS: Revenue Share, By Segment, 2022 (%)
  49. CLINIEXPERTS: Revenue Share, By Region, 2022 (%)
  50. IQVIA: Net Sales, 2022-2032 ($ Million)
  51. IQVIA: Revenue Share, By Segment, 2022 (%)
  52. IQVIA: Revenue Share, By Region, 2022 (%)
  53. Charles River Laboratories: Net Sales, 2022-2032 ($ Million)
  54. Charles River Laboratories: Revenue Share, By Segment, 2022 (%)
  55. Charles River Laboratories: Revenue Share, By Region, 2022 (%)
  56. KYMOS Group: Net Sales, 2022-2032 ($ Million)
  57. KYMOS Group: Revenue Share, By Segment, 2022 (%)
  58. KYMOS Group: Revenue Share, By Region, 2022 (%)
  59. Notrox Research: Net Sales, 2022-2032 ($ Million)
  60. Notrox Research: Revenue Share, By Segment, 2022 (%)
  61. Notrox Research: Revenue Share, By Region, 2022 (%)
  62. NorthEast BioAnalytical Laboratories LLC.: Net Sales, 2022-2032 ($ Million)
  63. NorthEast BioAnalytical Laboratories LLC.: Revenue Share, By Segment, 2022 (%)
  64. NorthEast BioAnalytical Laboratories LLC.: Revenue Share, By Region, 2022 (%)
  65. Malvern Panalytical Ltd: Net Sales, 2022-2032 ($ Million)
  66. Malvern Panalytical Ltd: Revenue Share, By Segment, 2022 (%)
  67. Malvern Panalytical Ltd: Revenue Share, By Region, 2022 (%)
  68. Synova Health: Net Sales, 2022-2032 ($ Million)
  69. Synova Health: Revenue Share, By Segment, 2022 (%)
  70. Synova Health: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2022
Tables & Figures:120
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:8.2%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies